Topics

White House Claims Pelosi Plan Would Cause Loss of 100 New Drugs Over 10 Years

19:00 EST 3 Dec 2019 | BioSpace

Two weeks after the pharmaceutical industry predicted dire consequences for innovation if the prescription price reduction plan proposed by House Speaker Nancy Pelosi passes, the White House is now echoing those concerns but suggesting even worse outcomes than industry analysts predict.

Original Article: White House Claims Pelosi Plan Would Cause Loss of 100 New Drugs Over 10 Years

NEXT ARTICLE

More From BioPortfolio on "White House Claims Pelosi Plan Would Cause Loss of 100 New Drugs Over 10 Years"

Quick Search

Relevant Topic

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...